TREA

79359336 - EVOX THERAPEUTICS

Follow

Information

  • Trademark
  • 79359336
  • Serial Number
    79359336
  • Filing Date
    December 01, 2022
    2 years ago
  • Transaction Date
    May 22, 2025
    7 days ago
  • Status Date
    May 21, 2025
    8 days ago
  • Published for Opposition Date
    January 21, 2025
    4 months ago
  • Location Date
    December 30, 2024
    5 months ago
  • Status Code
    774
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    ALLEN, BIANCA
  • Attorney Docket Number
    EVOX 2312584
    Attorney Name
    NANCY SABARRA
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EVOX THERAPEUTICS
Case File Statements
  • GS0051: Pharmaceuticals, namely, drug delivery agents in the form of exosomes consisting of compounds that facilitate the delivery of a wide range of pharmaceutical preparations; pharmaceutical preparations, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for therapeutic use, namely, for the release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, engineered exosomes to deliver pharmaceutical preparations in the nature of protein for genetic therapy; medicine, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; medical preparations, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; biological preparations for medical purposes, namely, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological preparations for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, muscular dystrophy; biological preparations comprising exosomes, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological preparations comprising a therapeutic target protein-loaded exosome that facilitates the delivery of pharmaceutical preparations, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological preparations comprising exosomes for pharmaceutical purposes that facilitate the delivery of pharmaceutical preparations, for the treatment of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies in the nature of mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; biological reagents for medical use, namely, drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; mixed biological preparations for medical purposes, namely, for the prevention and treatment of infectious diseases; mixed biological preparations for the prevention and treatment of infectious diseases; diagnostic reagents used in the fields of biological, genetic engineering and pharmaceutical research; diagnostic reagents comprising exosome used in the fields of biological, genetic engineering and pharmaceutical research; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle (EV)-based nucleic acid therapeutics for the prevention and treatment of infections or infectious diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancer, diabetes, metabolic syndrome, dementia, and aging associated pathologies, namely, mitochondrial disease, joint and ligament strains and tears, muscle atrophy, and muscular dystrophy; all of the foregoing excluding such goods in the fields of digestive diseases, gastrointestinal diseases, constipation, gut health, weight loss, appetite suppressants, dietetic preparations, nutrition, and enzymes
  • DS0000: "THERAPEUTICS"
  • GS0421: Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific research and analysis services in the field of pharmaceuticals; biological research; clinical research in the field of transformational therapeutics; providing medical research and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; all of the foregoing excluding such services in the fields of digestive diseases, gastrointestinal diseases, constipation, gut health, weight loss, appetite suppressants, dietetic preparations, nutrition, and enzymes
Case File Event Statements
  • 12/30/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC
  • 1/3/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/7/2023 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/11/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/23/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/24/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/4/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/5/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/31/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/27/2023 - a year ago
    11 - CORRECTION SENT TO IB Type: CRSN
  • 11/27/2023 - a year ago
    10 - CORRECTION CREATED FOR IB Type: CRCR
  • 4/4/2024 - a year ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/4/2024 - a year ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/6/2024 - a year ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/14/2024 - a year ago
    15 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/7/2024 - 11 months ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 6/20/2024 - 11 months ago
    17 - FINAL REFUSAL WRITTEN Type: CNFR
  • 6/20/2024 - 11 months ago
    18 - FINAL REFUSAL E-MAILED Type: GNFR
  • 6/20/2024 - 11 months ago
    19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 11/25/2024 - 6 months ago
    20 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 12/20/2024 - 5 months ago
    24 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 12/20/2024 - 5 months ago
    21 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 12/20/2024 - 5 months ago
    23 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 12/20/2024 - 5 months ago
    22 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 12/23/2024 - 5 months ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/23/2024 - 5 months ago
    27 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/23/2024 - 5 months ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/26/2024 - 5 months ago
    28 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 1/15/2025 - 4 months ago
    29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/21/2025 - 4 months ago
    30 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/20/2025 - 9 days ago
    33 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 5/20/2025 - 9 days ago
    34 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 5/21/2025 - 8 days ago
    35 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 5/21/2025 - 8 days ago
    36 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 1/30/2025 - 3 months ago
    32 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 1/21/2025 - 4 months ago
    31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB